RainDance Technologies, Inc. (RDT) is engaged in the development of microfluidic instruments and nanoreactors for the in-vitro diagnostic markets. Its major product is the professional laboratory system which is used in laboratories and research centres for automation of data-rich assays and screening protocols. Its technology is used in the detection of cancer cells in the blood and for improved enzyme eveolution. It also develops nanoreactor chips that are used in RNAi screening, enzyme profiling, screening and on-chip chemical synthesis. The company is headquartered in Connecticut, the US.
On September 18, 2009, the company entered into a collaboration with CLC bio to develop specialized software solutions for analysis of targeted resequencing data.